What does VETHERAPY do?

VETHERAPY is a veterinary practice in Anthisnes. Private Limited, started on 9 November 2011, 2 establishments.

What is the address of VETHERAPY?

The registered office of VETHERAPY is located at Chaussée de Liège 19b, 4160 Anthisnes.

Is VETHERAPY still active?

Yes. According to the CBE (29 October 2026) VETHERAPY is active, legal situation “Normale toestand”, started on 9 November 2011.

Is VETHERAPY registered on Peppol?

Yes, VETHERAPY is registered on the Peppol network with ID 0208:0840911410.

What is the enterprise number of VETHERAPY?

The enterprise number of VETHERAPY is BE0840911410.

When was VETHERAPY founded?

VETHERAPY was founded on 9 November 2011.

Who are the directors of VETHERAPY?

According to the 2025 annual accounts, the directors of VETHERAPY are: LO Vet., BT Pro.

Is VETHERAPY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 November 2011; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did VETHERAPY make in 2025?

VETHERAPY posted a profit after taxes of € 143,335 in financial year 2025.

What is the revenue of VETHERAPY?

As a small company, VETHERAPY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 162,870.

VETHERAPY (Private Limited) - Anthisnes - BE0840911410

Dossier VETHERAPY, printed on 29 October 2026 from databakkes.be/en/0840911410/vetherapy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

VETHERAPY from Anthisnes, company number BE0840911410, closed financial year 2025 with a result of € 143,335 after tax. For that financial year VETHERAPY recorded a gross margin of € 162,870 and equity of € 60,075. Compared with financial year 2024, the result moved from € 186,091 to € 143,335. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 2, 2026.

What it is worth Growing

€ 60,075

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 143,335

▼ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 323,446

▲ 21% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 137,000 paid out

96 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 389

▼ 46% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 23,383

▼ 20% vs 2024

€ 5,931 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 339,635

▲ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 128,317 Gross margin 2022: € 128,317 First fiscal year in the series	€ 119,936 Gross margin 2023: € 119,936 ▼ 7% vs 2022 (€ 128,317) Unfavourable step	€ 200,334 Gross margin 2024: € 200,334 ▲ 67% vs 2023 (€ 119,936) Favourable step	€ 162,870 Gross margin 2025: € 162,870 ▼ 19% vs 2024 (€ 200,334) Unfavourable step	▼ 19%
Profit after taxes	€ 124,928 Profit after taxes 2022: € 124,928 First fiscal year in the series	€ 112,680 Profit after taxes 2023: € 112,680 ▼ 10% vs 2022 (€ 124,928) Unfavourable step	€ 186,091 Profit after taxes 2024: € 186,091 ▲ 65% vs 2023 (€ 112,680) Favourable step	€ 143,335 Profit after taxes 2025: € 143,335 ▼ 23% vs 2024 (€ 186,091) Unfavourable step	▼ 23%
Equity	€ 106,568 Equity 2022: € 106,568 First fiscal year in the series	€ 113,248 Equity 2023: € 113,248 ▲ 6% vs 2022 (€ 106,568) Favourable step	€ 53,740 Equity 2024: € 53,740 ▼ 53% vs 2023 (€ 113,248) Unfavourable step	€ 60,075 Equity 2025: € 60,075 ▲ 12% vs 2024 (€ 53,740) Favourable step	▲ 12%
Total debts	€ 277,748 Total debts 2022: € 277,748 First fiscal year in the series	€ 364,053 Total debts 2023: € 364,053 ▲ 31% vs 2022 (€ 277,748) Unfavourable step	€ 511,461 Total debts 2024: € 511,461 ▲ 40% vs 2023 (€ 364,053) Unfavourable step	€ 556,368 Total debts 2025: € 556,368 ▲ 9% vs 2024 (€ 511,461) Unfavourable step	▲ 9%
Cash	€ 144,379 Cash 2022: € 144,379 First fiscal year in the series	€ 258,437 Cash 2023: € 258,437 ▲ 79% vs 2022 (€ 144,379) Favourable step	€ 267,909 Cash 2024: € 267,909 ▲ 4% vs 2023 (€ 258,437) Favourable step	€ 323,446 Cash 2025: € 323,446 ▲ 21% vs 2024 (€ 267,909) Favourable step	▲ 21%
Retained profit	€ 87,968 Retained profit 2022: € 87,968 First fiscal year in the series	€ 94,648 Retained profit 2023: € 94,648 ▲ 8% vs 2022 (€ 87,968) Favourable step	€ 35,140 Retained profit 2024: € 35,140 ▼ 63% vs 2023 (€ 94,648) Unfavourable step	€ 41,475 Retained profit 2025: € 41,475 ▲ 18% vs 2024 (€ 35,140) Favourable step	▲ 18%
Dividend	€ 118,000 Dividend 2022: € 118,000 First fiscal year in the series	€ 106,000 Dividend 2023: € 106,000 ▼ 10% vs 2022 (€ 118,000) Unchanged	€ 245,600 Dividend 2024: € 245,600 ▲ 132% vs 2023 (€ 106,000) Unchanged	€ 137,000 Dividend 2025: € 137,000 ▼ 44% vs 2024 (€ 245,600) Unchanged	▼ 44%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 29,104 Bank debt 2024: € 29,104 Unchanged (€ 0) Unfavourable step	€ 23,383 Bank debt 2025: € 23,383 ▼ 20% vs 2024 (€ 29,104) Favourable step	▼ 20%
Balance sheet total	€ 384,316 Balance sheet total 2022: € 384,316 First fiscal year in the series	€ 477,301 Balance sheet total 2023: € 477,301 ▲ 24% vs 2022 (€ 384,316) Unchanged	€ 565,201 Balance sheet total 2024: € 565,201 ▲ 18% vs 2023 (€ 477,301) Unchanged	€ 616,443 Balance sheet total 2025: € 616,443 ▲ 9% vs 2024 (€ 565,201) Unchanged	▲ 9%

Key figures of VETHERAPY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to VETHERAPY?

What happened at VETHERAPY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 2, 2026 New annual accounts for financial year 2025: profit of € 143,335 (▼ 23% vs 2024). filed late Source: NBB ↗
Jan 1, 2026 New establishment in Anthisnes. KBO
2018 BT Pro became a director. NBB
2018 LO Vet. became a director. NBB
Nov 9, 2011 New establishment in Ouffet. KBO
Nov 9, 2011 Start of the company according to the CBE. KBO

In short

From € 124,928 profit in 2022 to € 143,335 profit in 2025.

Paid € 11,661 in corporate taxes since 2022.

Best year ever: 2024, with € 186,091 profit.

Paid out € 606,600 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

LO Vet. BT Pro

VETHERAPY

Behind VETHERAPY are LO Vet. and BT Pro.

Directors

According to the 2025 annual accounts

LO Vet.

Director · represented by Olivier LIMBOURG

since 2018

BT Pro

Director · represented by Bruno RENETTE

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Liège 19b

4160 Anthisnes

2.205.557.987

Rue Brihî Tiyou 22

4590 Ouffet

Active since 9 November 2011

2.384.326.811

Chaussée de Liège 19 box b

4160 Anthisnes

Active since 1 January 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0840.911.410
VAT number: BE 0840.911.410
Registered office: Chaussée de Liège 19b, 4160 Anthisnes
Names & denominations: VETHERAPY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 November 2011
Peppol: Active · Active since 29 Jan 2026
Activities · NACE: Veterinaire diensten

View on CBE Public ↗ Annual accounts (NBB) ↗